Ernest D. Bush
Corporate Officer/Principal en PROMIS NEUROSCIENCES, INC. .
Origen de la red de primer grado Ernest D. Bush.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Biotechnology | 21 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Ernest D. Bush a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PEGASYSTEMS INC. | Information Technology Services | Director/Board Member | |
| GERON CORPORATION | Biotechnology | Investor Relations Contact Corporate Officer/Principal | |
| VERNALIS | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| NORDION INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MICROBIX BIOSYSTEMS INC. | Biotechnology | Director/Board Member | |
PNO Resources Ltd.
 PNO Resources Ltd. Other Metals/MineralsNon-Energy Minerals PNO Resources Ltd. engages in the acquisition and exploration of natural resource properties. The company was founded on February 22, 1983 and is headquartered in Vancouver, Canada. | Other Metals/Minerals | President | |
| WINDFALL GEOTEK INC. | Precious Metals | Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal | |
Cita NeuroPharmaceuticals, Inc.
 Cita NeuroPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cita Neuro Pharmaceuticals, Inc. develops and commercializes small molecule drugs. Its clinical drug portfolio consists of drugs for Parkinson's disease and neuropathic pain. Cita Neuro Pharmaceuticals was founded in 1997 by Brian Bennett, Roland Boegman, Khem Jha-mandas, James Reynolds and Gregory Thatcher and is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Chief Executive Officer | |
Translational Medicine India, Inc.
 Translational Medicine India, Inc. Miscellaneous Commercial ServicesCommercial Services Translational Medicine India, Inc. provides clinical research solutions. It offers a novel therapeutic with biomarkers and early stage clinical trials for researchers. The company is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Chairman | |
| NEUROTROPE, INC. | Pharmaceuticals: Major | Director/Board Member | |
ZyVersa Therapeutics Operating, Inc.
 ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology ZyVersa Therapeutics Operating, Inc. operates as a specialty pharmaceutical company, which develops and commercializes prescription pharmaceutical products. The firm focuses on developing products for the treatment of men?s health, as well as for other markets where current therapies are suboptimal and underdeveloped. It offers VAR 100, an oral formulation of native testosterone to treat male hypogonadism; and VAR 200 that minimizes and prevents kidney cell damage, and improves focal segmental glomerulosclerosis prognosis. The company was founded by Stephen C. Glover and Shawn M. Titcomb in 2014 and is headquartered in Weston, FL. | Pharmaceuticals: Major | Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
Bain & Co., Inc.
 Bain & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Bain & Co., Inc. provides management consulting services. It offers advisory services to the companies on their critical issues and opportunities: strategy, marketing, organization, operations, technology and mergers and acquisitions, across all industries and geographies. The company was founded in 1973 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Neurotrophic Bioscience, Inc.
 Neurotrophic Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Neurotrophic Bioscience, Inc. develops pharmaceutical products. | Pharmaceuticals: Major | President | |
| AMERESCO, INC. | Engineering & Construction | Investor Relations Contact | |
| McGill University | College/University | Undergraduate Degree Doctorate Degree | |
| University of Alberta | College/University | Undergraduate Degree Corporate Officer/Principal | |
| University of British Columbia | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Toronto | College/University | Corporate Officer/Principal Undergraduate Degree Graduate Degree | |
| McMaster University | College/University | Undergraduate Degree | |
| University of Illinois | College/University | Undergraduate Degree Doctorate Degree | |
Muscular Dystrophy Association, Inc.
 Muscular Dystrophy Association, Inc. Hospital/Nursing ManagementHealth Services MDA is the nonprofit health agency dedicated to curing muscular dystrophy, ALS and related diseases by funding worldwide research. The Association also provides comprehensive health care and support services, advocacy and education. MDA combats neuromuscular diseases through programs of worldwide research, comprehensive medical and support services, and far-reaching professional and public health education. With national headquarters in Tucson, MDA has more than 200 offices across the country, sponsors some 200 hospital-affiliated clinics and supports more than 330 research projects around the world. MDA supports more research on neuromuscular diseases than any other private-sector organization in the world. MDA scientists are in the forefront of gene therapy research and have uncovered the genetic defects responsible for several forms of muscular dystrophy, Charcot-Marie-Tooth disease, a form of amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease), childhood spinal muscular atrophy and several other neuromuscular conditions. The Association's comprehensive services program includes diagnostic and follow-up medical consultations, flu shots, support groups, MDA summer camps for youngsters, a medical equipment program, assistance with equipment repairs and resource referral. Through its national advocacy program, MDA works to make life better for people with muscular dystrophy and related muscle diseases by providing representation in matters of public policy and research advancement, nationally and internationally; and facilitating active involvement in these areas by the people it serves. MDA was created in 1950 by a group of adults with muscular dystrophy, parents of children with muscular dystrophy and a physician-scientist studying the disorder. Since its earliest days, it has been energized by its number-one volunteer and national chairman, entertainer Jerry Lewis. | Hospital/Nursing Management | Director/Board Member | |
| The Rockefeller University | College/University | Doctorate Degree | |
| International Institute for Management Development | College/University | Masters Business Admin | |
Institute of Corporate Directors
 Institute of Corporate Directors Miscellaneous Commercial ServicesCommercial Services The Institute of Corporate Directors is a not-for-profit, member-based association that serves as a resource and voice for directors and boards. The non-profit company is based in Toronto, Canada, and has subsidiaries in Canada. The ICD provides thought leadership through various publications and is a unified voice for directors. The Canadian company was founded by Brian J. Gibson, and Rahul K. Bhardwaj has been the CEO of the company since 2016. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Eisai Medical Research, Inc. | Corporate Officer/Principal | ||
| TITAN MEDICAL INC. | Medical Specialties | Director/Board Member | |
| UCB BioSciences, Inc. | Corporate Officer/Principal | ||
Kalgene Pharmaceuticals, Inc.
 Kalgene Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Kalgene Pharmaceuticals, Inc. develops and focuses on personalized cancer diagnostics and drugs. It offers drugs for epithelial and thyroid cancers. The firm's oncology programs are aimed at improving clinical and survival outcomes through the use of personalized medicine, with a particular focus on bladder, epithelial and thyroid cancers. It serves the biopharmaceutical, research and development and health industries. The company is headquartered in Kingston, Canada. | Medical/Nursing Services | Chairman | |
| IMMUNE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Operating Officer | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Akashi Therapeutics Inc
 Akashi Therapeutics Inc Pharmaceuticals: MajorHealth Technology Akashi Therapeutics Inc is a clinical stage biopharmaceutical company based in Cambridge, MA with subsidiaries in the United States. The private company has been granted orphan designation for DMD in both the US and Europe. The American company's mission is to develop treatments for Duchenne muscular dystrophy and other rare pediatric diseases. Akashi is developing a cocktail of medications with the goal of transforming Duchenne from a 100% fatal, aggressive muscle-wasting disease to a chronic, manageable condition. The application of HT-100 to DMD and other fibrotic diseases is based on pioneering work by Dr. Mark Pines at the Volcani Institute. Dosing and new patient enrollment in the phase 1b/2a clinical program have been suspended. The company was founded by leading patient organizations and biotechnology industry veterans and is managed by a seasoned team of drug development experts. The company was founded by Marc B. Blaustein, Thomas C. Wicka. | Pharmaceuticals: Major | Chief Executive Officer | |
TMG Biosciences LLC
 TMG Biosciences LLC Miscellaneous Commercial ServicesCommercial Services TMG Biosciences LLC provides biosurveillance and biotechnology consulting services. It assists clients to execute biosurveillance and microbial detection/characterization programs and providing subject matter expertise on biotechnology instrumentation. The company is headquartered in Austin, TX. | Miscellaneous Commercial Services | Director/Board Member | |
Sunovion CNS Development Canada Ulc
 Sunovion CNS Development Canada Ulc Pharmaceuticals: MajorHealth Technology Sunovion CNS Development Canada Ulc develops pharmaceuticals products. The company is headquartered in Vancouver, Canada. | Pharmaceuticals: Major | Chief Executive Officer | |
| POND TECHNOLOGIES HOLDINGS INC. | Pharmaceuticals: Other | Director/Board Member | |
| XORTX THERAPEUTICS INC. | Pharmaceuticals: Major | Chairman | |
| Virtua LLC | Founder Founder | ||
Valo Therapeutics Oy
 Valo Therapeutics Oy Pharmaceuticals: MajorHealth Technology Valo Therapeutics Oy is an immunotherapy company based in Helsinki, FI. The Finnish company is focused on developing innovative immunotherapy approaches against cancer and infectious disease. Valo Therapeutics's lead platform, PeptiCRAd, was developed out of the laboratory of Professor Vincenzo Cerullo at the University of Helsinki. The company is also developing PeptiEnv and PeptiVax, among other neoantigen strategies, in collaboration with Professor Cerullo. The company's PeptiChip technology enables the rapid and accurate identification of tumor antigens. Valo Therapeutics is also developing antigen-coated oncolytic viruses as anti-cancer therapeutic vaccines. The company was founded in 2016, and Paul Grant Higham has been the CEO of the company since 2020. | Pharmaceuticals: Major | Director/Board Member | |
| Ridgeline Therapeutics | Chairman | ||
Provectra Therapeutics, Inc.
 Provectra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provectra Therapeutics, Inc. manufactures pharmaceutical products. The private company is based in Chapel Hill, NC. The company was founded by Larry Douglas Altstiel. | Pharmaceuticals: Major | Chief Executive Officer |
Estadísticas
Internacional
| Canadá | 24 |
| Estados Unidos | 23 |
| Reino Unido | 2 |
| India | 2 |
| Suiza | 2 |
Sectorial
| Health Technology | 26 |
| Consumer Services | 11 |
| Commercial Services | 5 |
| Health Services | 4 |
| Non-Energy Minerals | 3 |
Operativa
| Director/Board Member | 63 |
| Director of Finance/CFO | 42 |
| Corporate Officer/Principal | 40 |
| Independent Dir/Board Member | 21 |
| President | 17 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Daniel Geffken | 53 |
| Anthony Giovinazzo | 22 |
| William Wyman | 21 |
| Neil Warma | 15 |
| Gail Farfel | 15 |
| Eugene Williams | 13 |
| Larry Altstiel | 12 |
| Elliot Goldstein | 10 |
| Richard Gregory | 8 |
| Neil Cashman | 8 |
| Gavin Malenfant | 6 |
| Maggie Shafmaster | 6 |
| Johanne Kaplan | 5 |
| Josh Mandel-Brehm | 5 |
| James Kupiec | 5 |
- Bolsa de valores
- Insiders
- Ernest D. Bush
- Conexiones Empresas
